-
Mashup Score: 11
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3EMERALD Ph III Study in discussion w/ Dr. Aditya Bardia (now FDA Approved) – ONC Brothers - 1 year(s) ago
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet-
@dradityabardia from @MGHCancerCenter walks us through #EMERALD study & how to incorporate this recent approval of #elacestrant in our clinical practice: Full Int: - https://t.co/0RucWrTCy4 - Also on the “Oncology Brothers” podcast #OncJC #MedTwitter #OncEd #bcsm @FDAOncology https://t.co/MlEkofaA8v
-
-
Mashup Score: 2
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet
Our conversation w/ @GIcancerDoc on #MOUNTAINEER: #Tucatinib + #Trastuzumab in Her2+ met #ColorectalCancer Full Int: - https://t.co/oT4KBpWayU - Also on “Oncology Brothers”🎙 #OncJC #MedTwitter #crcsm #OncEd @pashtoonkasi @VivekSubbiah @marklewismd @weldeiry #oncology #gism https://t.co/lPujwmnXx2